top of page

Nexavar by Bayer is a medicine approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma). Its generic name is Sorafenib. It has both US FDA & European Commision approval for use in the treatment of advanced renal cancer & liver cancer. Sorafenib is a small molecular inhibitor of several Tyrosine protein kinases (VEGFR and PDGFR) and Raf kinases. It is available in 200 mg dosage & 60 tablets/bottle packing.

Manufacturer: Bayer



bottom of page